444 related articles for article (PubMed ID: 15169914)
1. The ETS transcription factor ESE-1 transforms MCF-12A human mammary epithelial cells via a novel cytoplasmic mechanism.
Prescott JD; Koto KS; Singh M; Gutierrez-Hartmann A
Mol Cell Biol; 2004 Jun; 24(12):5548-64. PubMed ID: 15169914
[TBL] [Abstract][Full Text] [Related]
2. Mapping of ESE-1 subdomains required to initiate mammary epithelial cell transformation via a cytoplasmic mechanism.
Prescott JD; Poczobutt JM; Tentler JJ; Walker DM; Gutierrez-Hartmann A
Mol Cancer; 2011 Aug; 10():103. PubMed ID: 21871131
[TBL] [Abstract][Full Text] [Related]
3. The epithelial-specific ETS transcription factor ESX/ESE-1/Elf-3 modulates breast cancer-associated gene expression.
Eckel KL; Tentler JJ; Cappetta GJ; Diamond SE; Gutierrez-Hartmann A
DNA Cell Biol; 2003 Feb; 22(2):79-94. PubMed ID: 12713734
[TBL] [Abstract][Full Text] [Related]
4. ESX induces transformation and functional epithelial to mesenchymal transition in MCF-12A mammary epithelial cells.
Schedin PJ; Eckel-Mahan KL; McDaniel SM; Prescott JD; Brodsky KS; Tentler JJ; Gutierrez-Hartmann A
Oncogene; 2004 Mar; 23(9):1766-79. PubMed ID: 14767472
[TBL] [Abstract][Full Text] [Related]
5. Phosphorylation-dependent regulation of stability and transforming potential of ETS transcriptional factor ESE-1 by p21-activated kinase 1.
Manavathi B; Rayala SK; Kumar R
J Biol Chem; 2007 Jul; 282(27):19820-30. PubMed ID: 17491012
[TBL] [Abstract][Full Text] [Related]
6. Characterization of ESE-2, a novel ESE-1-related Ets transcription factor that is restricted to glandular epithelium and differentiated keratinocytes.
Oettgen P; Kas K; Dube A; Gu X; Grall F; Thamrongsak U; Akbarali Y; Finger E; Boltax J; Endress G; Munger K; Kunsch C; Libermann TA
J Biol Chem; 1999 Oct; 274(41):29439-52. PubMed ID: 10506207
[TBL] [Abstract][Full Text] [Related]
7. Unique and selective effects of five Ets family members, Elf3, Ets1, Ets2, PEA3, and PU.1, on the promoter of the type II transforming growth factor-beta receptor gene.
Kopp JL; Wilder PJ; Desler M; Kim JH; Hou J; Nowling T; Rizzino A
J Biol Chem; 2004 May; 279(19):19407-20. PubMed ID: 14976186
[TBL] [Abstract][Full Text] [Related]
8. Differentiation-specific transcriptional regulation of the ESE-2 gene by a novel keratinocyte-restricted factor.
Tummala R; Sinha S
J Cell Biochem; 2006 Mar; 97(4):766-81. PubMed ID: 16229011
[TBL] [Abstract][Full Text] [Related]
9. Isolation and characterization of a novel epithelium-specific transcription factor, ESE-1, a member of the ets family.
Oettgen P; Alani RM; Barcinski MA; Brown L; Akbarali Y; Boltax J; Kunsch C; Munger K; Libermann TA
Mol Cell Biol; 1997 Aug; 17(8):4419-33. PubMed ID: 9234700
[TBL] [Abstract][Full Text] [Related]
10. ESX: a structurally unique Ets overexpressed early during human breast tumorigenesis.
Chang CH; Scott GK; Kuo WL; Xiong X; Suzdaltseva Y; Park JW; Sayre P; Erny K; Collins C; Gray JW; Benz CC
Oncogene; 1997 Apr; 14(13):1617-22. PubMed ID: 9129154
[TBL] [Abstract][Full Text] [Related]
11. Identification of epithelial-specific ETS-1 (ESE-1) as a tumor suppressor and molecular target of green tea compound, EGCG.
Ha T; Lee J; Lou Z; Lee BS; Kim CH; Lee SH
Mol Carcinog; 2019 Jun; 58(6):922-932. PubMed ID: 30676667
[TBL] [Abstract][Full Text] [Related]
12. Multiple roles of the epithelium-specific ETS transcription factor, ESE-1, in development and disease.
Oliver JR; Kushwah R; Hu J
Lab Invest; 2012 Mar; 92(3):320-30. PubMed ID: 22157719
[TBL] [Abstract][Full Text] [Related]
13. Determination of the consensus DNA-binding sequence and a transcriptional activation domain for ESE-2.
Choi YS; Sinha S
Biochem J; 2006 Sep; 398(3):497-507. PubMed ID: 16704374
[TBL] [Abstract][Full Text] [Related]
14. Regulation of Ets function by protein - protein interactions.
Li R; Pei H; Watson DK
Oncogene; 2000 Dec; 19(55):6514-23. PubMed ID: 11175367
[TBL] [Abstract][Full Text] [Related]
15. The epithelial-specific Ets factors occupy a unique position in defining epithelial proliferation, differentiation and carcinogenesis.
Feldman RJ; Sementchenko VI; Watson DK
Anticancer Res; 2003; 23(3A):2125-31. PubMed ID: 12894586
[TBL] [Abstract][Full Text] [Related]
16. ESE-1 is a novel transcriptional mediator of angiopoietin-1 expression in the setting of inflammation.
Brown C; Gaspar J; Pettit A; Lee R; Gu X; Wang H; Manning C; Voland C; Goldring SR; Goldring MB; Libermann TA; Gravallese EM; Oettgen P
J Biol Chem; 2004 Mar; 279(13):12794-803. PubMed ID: 14715662
[TBL] [Abstract][Full Text] [Related]
17. Evidence for a cancer-specific switch at the CDK4 promoter with loss of control by both USF and c-Myc.
Pawar SA; Szentirmay MN; Hermeking H; Sawadogo M
Oncogene; 2004 Aug; 23(36):6125-35. PubMed ID: 15208653
[TBL] [Abstract][Full Text] [Related]
18. Altered Ets transcription factor activity in prostate tumor cells inhibits anchorage-independent growth, survival, and invasiveness.
Foos G; Hauser CA
Oncogene; 2000 Nov; 19(48):5507-16. PubMed ID: 11114728
[TBL] [Abstract][Full Text] [Related]
19. Positive and negative modulation of the transcriptional activity of the ETS factor ESE-1 through interaction with p300, CREB-binding protein, and Ku 70/86.
Wang H; Fang R; Cho JY; Libermann TA; Oettgen P
J Biol Chem; 2004 Jun; 279(24):25241-50. PubMed ID: 15075319
[TBL] [Abstract][Full Text] [Related]
20. Exon 4-encoded acidic domain in the epithelium-restricted Ets factor, ESX, confers potent transactivating capacity and binds to TATA-binding protein (TBP).
Chang CH; Scott GK; Baldwin MA; Benz CC
Oncogene; 1999 Jun; 18(25):3682-95. PubMed ID: 10391676
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
